Furthermore, intravenous administration of VSV-IFNβ in immunocompetent mice showed that a sufficient number of VSV-IFNβ virions reached the tumor site, carrying out its antitumor activity, and killed disseminated myeloma cells, increasing the survival of the mice. Here, IFNB1 is linked to neoplasm.